CAS 206275-15-2

Benzamide, 4-[[(7-bromo-3,4-dihydro-2-methyl-4-oxo-6-quinazolinyl)methyl]-2-propyn-1-ylamino]-N-(3-pyridinylmethyl)-

CAS : 206275-15-2

Formule : C₂₆H₂₂BrN₅O₂

Degré de pureté : 95%

Masse moléculaire : 516.3892

Ref: IN-DA002IEH

CB30865

CAS : 206275-15-2

CB30865 is a proliferation inhibitor that has been shown to be effective in the treatment of cancer. It has been shown to inhibit cell growth and induce cell death in vitro and in vivo. CB30865 binds to a cellular target that is not yet identified, which may be due to its chemical structure. This drug has been shown to have no effect on healthy cells, making it an ideal candidate for the treatment of cancer. It also has potential uses as a diagnostic agent for inflammatory diseases or other diseases with specific targets.

Formule : C₂₆H₂₂BrN₅O₂

Degré de pureté : Min. 95%

Masse moléculaire : 516.39 g/mol

Ref: 3D-GIA27515

CB30865

CAS : 206275-15-2

CB30865 (ZM 242421) is a selective and highly effective nicotinamide phosphoribosyltransferase (Nampt) inhibitor with potential antitumor activity.

Formule : C₂₆H₂₂BrN₅O₂

Degré de pureté : 99.04%

Couleur et forme : Solid

Masse moléculaire : 516.39

Ref: TM-T14882